Iran war and drug supplies: Don’t panic, but pay attention
Chief Healthcare Executive explores how the war in Iran could affect pharmaceutical supply chains, with experts advising providers to monitor developments but avoid premature stockpiling. The article includes insights from Kyle MacKinnon, senior director of operational excellence at Premier, and Mark Hendrickson, director of supply chain policy at Premier, who note that hospitals currently have safety stock in place and widespread disruptions are not expected in the near term. However, they caution that prolonged conflict could increase costs and create downstream supply challenges.
